Minervini Andrea, Giubilei Gianluca, Masieri Lorenzo, Lanzi Federico, Serni Sergio, Carini Marco
Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.
BJU Int. 2007 Apr;99(4):887-91. doi: 10.1111/j.1464-410X.2006.06702.x. Epub 2007 Jan 16.
To report on the role of simple enucleation for treating renal angiomyolipoma (AML) in a series of patients treated in our department.
We retrospectively reviewed the data of all 37 patients with a histopathological diagnosis of renal AML who had either radical nephrectomy (three) or nephron-sparing surgery by simple enucleation (34) between January 1986 and December 2005. Indications for intervention included either symptomatic AML or a tumour of >4 cm, regardless to the presence of symptoms or renal masses suspicious of malignancy. The patients' status was evaluated last in October 2006.
The mean (sd, median, range) pathological tumour size was 5.2 (3.4, 4.8, 1.5-15) cm; five patients (15%) were affected by tuberous sclerosis. Simple enucleation was successful in all patients but in three (9%) a sharp dissection a few millimetres from the tumour was used during critical steps of the procedure where it seemed difficult to define the right plane of enucleation. Warm ischaemia was used in 79% of patients, with a mean ischaemic time of 11.2 min. Two patients (6%) required renal hypothermia. A simple parenchymal compression was used in five cases (15%). The mean (range) intraoperative blood loss was 170 (70-650) mL. None of the patients had postoperative bleeding requiring re-intervention but one (3%) required two units of blood after surgery. There were no major complications, e.g. prolonged acute tubular necrosis/chronic renal insufficiency and urinary leakage/urinoma, but two patients had urosepsis not associated with perirenal fluid collection and that required targeted antibiotic therapy. At a mean (median, range) follow-up of 56 (50.5, 10-120) months none of the patients had local tumour recurrence. Two patients had a small AML elsewhere in the operated kidney, detected 18 and 36 months after surgery, with a kidney recurrence rate of 6%.
Our data confirm the optimum results of simple enucleation for renal AMLs; this technique provides excellent long-term local control and no patient had urinary leakage/fistula afterward.
报告单纯剜除术在我科治疗的一系列肾血管平滑肌脂肪瘤(AML)患者中的作用。
我们回顾性分析了1986年1月至2005年12月期间37例经组织病理学诊断为肾AML患者的数据,其中3例行根治性肾切除术,34例行单纯剜除术保留肾单位手术。干预指征包括有症状的AML或肿瘤直径>4 cm,无论有无症状或怀疑有恶性肾肿块。患者的状况于2006年10月进行最后评估。
病理肿瘤平均(标准差、中位数、范围)大小为5.2(3.4、4.8、1.5 - 15)cm;5例患者(15%)患有结节性硬化症。所有患者单纯剜除术均成功,但3例(9%)在手术关键步骤中,当似乎难以确定正确的剜除平面时,在距肿瘤几毫米处进行了锐性分离。79%的患者采用了热缺血,平均缺血时间为11.2分钟。2例患者(6%)需要肾低温。5例(15%)采用了简单的实质压迫。术中平均(范围)失血量为170(70 - 650)mL。无患者术后出血需要再次干预,但1例(3%)术后需要输注2个单位的血液。无重大并发症,如延长的急性肾小管坏死/慢性肾功能不全和尿漏/尿瘤,但2例患者发生了与肾周积液无关的尿脓毒症,需要针对性的抗生素治疗。平均(中位数、范围)随访56(50.5、10 - 120)个月,无患者出现局部肿瘤复发。2例患者在手术肾脏的其他部位发现小的AML,分别在术后18个月和36个月发现,肾脏复发率为6%。
我们的数据证实了单纯剜除术治疗肾AML的最佳效果;该技术提供了良好的长期局部控制,术后无患者发生尿漏/瘘。